{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T21:28:13Z","timestamp":1792790893720,"version":"4.5.0"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,8,14]],"date-time":"2023-08-14T00:00:00Z","timestamp":1691971200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,8,14]],"date-time":"2023-08-14T00:00:00Z","timestamp":1691971200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100015569","name":"Canadian Consortium on Neurodegeneration in Aging","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100015569","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001804","name":"Canada Research Chairs program","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100001804","id-type":"DOI","asserted-by":"crossref"}]},{"name":"River Fund at Calgary Foundation","id":[{"id":"https:\/\/ror.org\/042503j14","id-type":"ROR","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100009307","name":"Parkinson Canada","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100009307","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Parkinson Qu\u00e9bec","id":[{"id":"https:\/\/ror.org\/006hdm859","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Fonds de recherche du Qu\u00e9bec Sant\u00e9","id":[{"id":"https:\/\/ror.org\/00w3qhf76","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Fondation IUGM"},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["PJT-1661232"],"award-info":[{"award-number":["PJT-1661232"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Tourmaline Oil Chair in Parkinson\u2019s Disease"},{"DOI":"10.13039\/501100019217","name":"Institut de Valorisation des Donn\u00e9es","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100019217","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Patients with Parkinson\u2019s Disease (PD) often suffer from cognitive decline. Accurate prediction of cognitive decline is essential for early treatment of at-risk patients. The aim of this study was to develop and evaluate a multimodal machine learning model for the prediction of continuous cognitive decline in patients with early PD. We included 213 PD patients from the Parkinson\u2019s Progression Markers Initiative (PPMI) database. Machine learning was used to predict change in Montreal Cognitive Assessment (MoCA) score using the difference between baseline and 4-years follow-up data as outcome. Input features were categorized into four sets: clinical test scores, cerebrospinal fluid (CSF) biomarkers, brain volumes, and genetic variants. All combinations of input feature sets were added to a basic model, which consisted of demographics and baseline cognition. An iterative scheme using RReliefF-based feature ranking and support vector regression in combination with tenfold cross validation was used to determine the optimal number of predictive features and to evaluate model performance for each combination of input feature sets. Our best performing model consisted of a combination of the basic model, clinical test scores and CSF-based biomarkers. This model had 12 features, which included baseline cognition, CSF phosphorylated tau, CSF total tau, CSF amyloid-beta\n                    <jats:sub>1-42<\/jats:sub>\n                    , geriatric depression scale (GDS) scores, and anxiety scores. Interestingly, many of the predictive features in our model have previously been associated with Alzheimer\u2019s disease, showing the importance of assessing Alzheimer\u2019s disease pathology in patients with Parkinson\u2019s disease.\n                  <\/jats:p>","DOI":"10.1038\/s41598-023-37644-6","type":"journal-article","created":{"date-parts":[[2023,8,14]],"date-time":"2023-08-14T06:02:56Z","timestamp":1691992976000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":58,"title":["Machine learning-based prediction of longitudinal cognitive decline in early Parkinson\u2019s disease using multimodal features"],"prefix":"10.1038","volume":"13","author":[{"given":"Hannes","family":"Almgren","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Milton","family":"Camacho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandru","family":"Hanganu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mekale","family":"Kibreab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Camicioli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zahinoor","family":"Ismail","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nils D.","family":"Forkert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oury","family":"Monchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,8,14]]},"reference":[{"key":"37644_CR1","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1016\/S1474-4422(18)30295-3","volume":"17","author":"ER Dorsey","year":"2018","unstructured":"Dorsey, E. R. et al. Global, regional, and national burden of Parkinson\u2019s disease, 1990\u20132016: A systematic analysis for the Global Burden of Disease Study 2016. The Lancet Neurology 17, 939\u2013953. https:\/\/doi.org\/10.1016\/S1474-4422(18)30295-3 (2018).","journal-title":"The Lancet Neurology"},{"key":"37644_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41572-021-00280-3","volume":"7","author":"D Aarsland","year":"2021","unstructured":"Aarsland, D. et al. Parkinson disease-associated cognitive impairment. Nat. Rev. Dis. Primers. 7, 1\u201321. https:\/\/doi.org\/10.1038\/s41572-021-00280-3 (2021).","journal-title":"Nat. Rev. Dis. Primers."},{"key":"37644_CR3","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1212\/WNL.0000000000000066","volume":"82","author":"AJ Yarnall","year":"2014","unstructured":"Yarnall, A. J. et al. Characterizing mild cognitive impairment in incident Parkinson disease: The ICICLE-PD Study. Neurology 82, 308\u2013316. https:\/\/doi.org\/10.1212\/WNL.0000000000000066 (2014).","journal-title":"Neurology"},{"key":"37644_CR4","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2019.00021","author":"A Nicoletti","year":"2019","unstructured":"Nicoletti, A. et al. Incidence of mild cognitive impairment and dementia in Parkinson\u2019s disease: The Parkinson\u2019s disease cognitive impairment study. Front. Aging Neurosci. https:\/\/doi.org\/10.3389\/fnagi.2019.00021 (2019).","journal-title":"Front. Aging Neurosci."},{"key":"37644_CR5","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1212\/WNL.0000000000002001","volume":"85","author":"K Pigott","year":"2015","unstructured":"Pigott, K. et al. Longitudinal study of normal cognition in Parkinson disease. Neurology 85, 1276\u20131282. https:\/\/doi.org\/10.1212\/WNL.0000000000002001 (2015).","journal-title":"Neurology"},{"key":"37644_CR6","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1002\/ana.25236","volume":"83","author":"V Kotagal","year":"2018","unstructured":"Kotagal, V., Spino, C., Bohnen, N. I., Koeppe, R. & Albin, R. L. Serotonin, \u03b2-amyloid, and cognition in Parkinson disease. Ann. Neurol. 83, 994\u20131002. https:\/\/doi.org\/10.1002\/ana.25236 (2018).","journal-title":"Ann. Neurol."},{"key":"37644_CR7","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1111\/j.1755-5949.2010.00166.x","volume":"17","author":"T van Laar","year":"2021","unstructured":"van Laar, T., De Deyn, P. P., Aarsland, D., Barone, P. & Galvin, J. E. Effects of cholinesterase inhibitors in Parkinson\u2019s disease dementia: A review of clinical data. CNS Neurosci. Ther. 17, 428\u2013441. https:\/\/doi.org\/10.1111\/j.1755-5949.2010.00166.x (2021).","journal-title":"CNS Neurosci. Ther."},{"key":"37644_CR8","doi-asserted-by":"publisher","first-page":"1843","DOI":"10.1212\/WNL.0000000000002145","volume":"85","author":"IHK Leung","year":"2015","unstructured":"Leung, I. H. K. et al. Cognitive training in Parkinson disease: A systematic review and meta-analysis. Neurology 85, 1843\u20131851. https:\/\/doi.org\/10.1212\/WNL.0000000000002145 (2015).","journal-title":"Neurology"},{"key":"37644_CR9","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/j.neubiorev.2017.01.021","volume":"75","author":"L Dinkelbach","year":"2017","unstructured":"Dinkelbach, L., Brambilla, M., Manenti, R. & Brem, A. K. Non-invasive brain stimulation in Parkinson\u2019s disease: Exploiting crossroads of cognition and mood. Neurosci. Biobehav. Rev. 75, 407\u2013418. https:\/\/doi.org\/10.1016\/j.neubiorev.2017.01.021 (2017).","journal-title":"Neurosci. Biobehav. Rev."},{"key":"37644_CR10","doi-asserted-by":"publisher","first-page":"e0193113","DOI":"10.1371\/journal.pone.0193113","volume":"13","author":"FC da Silva","year":"2018","unstructured":"da Silva, F. C. et al. Effects of physical exercise programs on cognitive function in Parkinson\u2019s disease patients: A systematic review of randomized controlled trials of the last 10 years. PLoS ONE 13, e0193113. https:\/\/doi.org\/10.1371\/journal.pone.0193113 (2018).","journal-title":"PLoS ONE"},{"key":"37644_CR11","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1002\/mds.24893","volume":"27","author":"I Litvan","year":"2012","unstructured":"Litvan, I. et al. Diagnostic criteria for mild cognitive impairment in Parkinson\u2019s disease: Movement Disorder Society Task Force guidelines: PD-MCI Diagnostic Criteria. Mov. Disord. 27, 3. https:\/\/doi.org\/10.1002\/mds.24893 (2012).","journal-title":"Mov. Disord."},{"key":"37644_CR12","doi-asserted-by":"publisher","first-page":"1581","DOI":"10.1111\/j.1742-1241.2008.01869.x","volume":"62","author":"W Poewe","year":"2008","unstructured":"Poewe, W. et al. Diagnosis and management of Parkinson\u2019s disease dementia. Int. J. Clin. Pract. 62, 1581\u20131587. https:\/\/doi.org\/10.1111\/j.1742-1241.2008.01869.x (2008).","journal-title":"Int. J. Clin. Pract."},{"key":"37644_CR13","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1093\/brain\/awy072","volume":"141","author":"J Schulz","year":"2018","unstructured":"Schulz, J., Pagano, G., Fern\u00e1ndez Bonfante, J. A., Wilson, H. & Politis, M. Nucleus basalis of Meynert degeneration precedes and predicts cognitive impairment in Parkinson\u2019s disease. Brain 141, 5. https:\/\/doi.org\/10.1093\/brain\/awy072 (2018).","journal-title":"Brain"},{"key":"37644_CR14","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1007\/s00702-019-02125-6","volume":"127","author":"H Wilson","year":"2020","unstructured":"Wilson, H. et al. Predict cognitive decline with clinical markers in Parkinson\u2019s disease (PRECODE-1). J. Neural Transm. 127, 51\u201359. https:\/\/doi.org\/10.1007\/s00702-019-02125-6 (2020).","journal-title":"J. Neural Transm."},{"key":"37644_CR15","doi-asserted-by":"publisher","first-page":"203383","DOI":"10.1148\/radiol.2021203383","volume":"300","author":"N-Y Shin","year":"2021","unstructured":"Shin, N.-Y. et al. Cortical thickness from MRI to predict conversion from mild cognitive impairment to dementia in Parkinson disease: A machine learning-based model. Radiology 300, 203383. https:\/\/doi.org\/10.1148\/radiol.2021203383 (2021).","journal-title":"Radiology"},{"key":"37644_CR16","doi-asserted-by":"publisher","unstructured":"Smith, N. et al. Predicting future cognitive impairment in de novo parkinson\u2019s disease using clinical data and structural MRI. Preprint at https:\/\/www.medrxiv.org\/content\/https:\/\/doi.org\/10.1101\/2021.08.13.21261662v1 (2021).","DOI":"10.1101\/2021.08.13.21261662v1"},{"key":"37644_CR17","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1093\/braincomms\/fcac040","volume":"4","author":"D B\u00e4ckstr\u00f6m","year":"2022","unstructured":"B\u00e4ckstr\u00f6m, D. et al. Prediction and early biomarkers of cognitive decline in Parkinson disease and atypical Parkinsonism: A population-based study. Brain Commun. 4, 2. https:\/\/doi.org\/10.1093\/braincomms\/fcac040 (2022).","journal-title":"Brain Commun."},{"key":"37644_CR18","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1212\/WNL.0b013e3181f39a78","volume":"75","author":"A Siderowf","year":"2010","unstructured":"Siderowf, A. et al. CSF amyloid \u03b2 1\u201342 predicts cognitive decline in Parkinson disease. Neurology 75, 1055\u20131061. https:\/\/doi.org\/10.1212\/WNL.0b013e3181f39a78 (2010).","journal-title":"Neurology"},{"key":"37644_CR19","doi-asserted-by":"publisher","first-page":"224","DOI":"10.3389\/fneur.2014.00224","volume":"5","author":"F De Marchi","year":"2014","unstructured":"De Marchi, F., Carecchio, M., Cantello, R. & Comi, C. Predicting cognitive decline in Parkinson\u2019s disease: Can we ask the genes?. Front. Neurol. 5, 224. https:\/\/doi.org\/10.3389\/fneur.2014.00224 (2014).","journal-title":"Front. Neurol."},{"key":"37644_CR20","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1016\/S1474-4422(17)30122-9","volume":"16","author":"G Liu","year":"2017","unstructured":"Liu, G. et al. Prediction of cognition in Parkinson\u2019s disease with a clinical\u2013genetic score: A longitudinal analysis of nine cohorts. The Lancet Neurology 16, 620\u2013629. https:\/\/doi.org\/10.1016\/S1474-4422(17)30122-9 (2017).","journal-title":"The Lancet Neurology"},{"key":"37644_CR21","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.neurobiolaging.2022.06.008","volume":"118","author":"B Hebling Vieira","year":"2022","unstructured":"Hebling Vieira, B. et al. Predicting future cognitive decline from non-brain and multimodal brain imaging data in healthy and pathological aging. Neurobiol. Aging 118, 55\u201365. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2022.06.008 (2022).","journal-title":"Neurobiol. Aging"},{"key":"37644_CR22","doi-asserted-by":"publisher","first-page":"e0175674","DOI":"10.1371\/journal.pone.0175674","volume":"12","author":"C Caspell-Garcia","year":"2017","unstructured":"Caspell-Garcia, C. et al. Multiple modality biomarker prediction of cognitive impairment in prospectively followed de novo Parkinson disease. PLoS ONE 12, e0175674. https:\/\/doi.org\/10.1371\/journal.pone.0175674 (2017).","journal-title":"PLoS ONE"},{"key":"37644_CR23","doi-asserted-by":"publisher","first-page":"062001","DOI":"10.1088\/1741-2552\/abbff2","volume":"17","author":"LL Vercio","year":"2020","unstructured":"Vercio, L. L. et al. Supervised machine learning tools: A tutorial for clinicians. J. Neural Eng. 17, 062001. https:\/\/doi.org\/10.1088\/1741-2552\/abbff2 (2020).","journal-title":"J. Neural Eng."},{"key":"37644_CR24","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1139\/gen-2020-0131","volume":"64","author":"SJ MacEachern","year":"2021","unstructured":"MacEachern, S. J. & Forkert, N. D. Machine learning for precision medicine. Genome 64, 416\u2013425. https:\/\/doi.org\/10.1139\/gen-2020-0131 (2021).","journal-title":"Genome"},{"key":"37644_CR25","doi-asserted-by":"publisher","first-page":"2324","DOI":"10.1002\/mds.28661","volume":"36","author":"VJ Geraedts","year":"2021","unstructured":"Geraedts, V. J. et al. Preoperative electroencephalography-based machine learning predicts cognitive deterioration after subthalamic deep brain stimulation. Mov. Disord. 36, 2324\u20132334. https:\/\/doi.org\/10.1002\/mds.28661 (2021).","journal-title":"Mov. Disord."},{"key":"37644_CR26","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1016\/j.neuron.2014.01.045","volume":"81","author":"T Kanekiyo","year":"2014","unstructured":"Kanekiyo, T., Xu, H. & Bu, G. ApoE and A\u03b2 in Alzheimer\u2019s disease: Accidental encounters or partners?. Neuron 81, 740\u2013754. https:\/\/doi.org\/10.1016\/j.neuron.2014.01.045 (2014).","journal-title":"Neuron"},{"issue":"6","key":"37644_CR27","doi-asserted-by":"publisher","first-page":"1526","DOI":"10.3390\/jcm11061526","volume":"11","author":"MS Baek","year":"2022","unstructured":"Baek, M. S., Lee, N., Kim, J. W. & Hong, J. Y. Association of hippocampal subfield volumes with amyloid-beta deposition in Alzheimer\u2019s disease. J. Clin. Med. 11(6), 1526. https:\/\/doi.org\/10.3390\/jcm11061526 (2022).","journal-title":"J. Clin. Med."},{"key":"37644_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2021.100988","author":"A Sturchio","year":"2021","unstructured":"Sturchio, A. et al. High cerebrospinal amyloid-\u03b2 42 is associated with normal cognition in individuals with brain amyloidosis. EClinicalMedicine https:\/\/doi.org\/10.1016\/j.eclinm.2021.100988 (2021).","journal-title":"EClinicalMedicine"},{"key":"37644_CR29","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.1093\/brain\/awr031","volume":"134","author":"Y Compta","year":"2011","unstructured":"Compta, Y. et al. Lewy- and Alzheimer-type pathologies in Parkinson\u2019s disease dementia: Which is more important?. Brain 134, 1493\u20131505. https:\/\/doi.org\/10.1093\/brain\/awr031 (2011).","journal-title":"Brain"},{"key":"37644_CR30","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1038\/nrn3549","volume":"14","author":"DJ Irwin","year":"2013","unstructured":"Irwin, D. J., Lee, V.M.-Y. & Trojanowski, J. Q. Parkinson\u2019s disease dementia: Convergence of \u03b1-synuclein, tau and amyloid-\u03b2 pathologies. Nat. Rev. Neurosci. 14, 626\u2013636. https:\/\/doi.org\/10.1038\/nrn3549 (2013).","journal-title":"Nat. Rev. Neurosci."},{"key":"37644_CR31","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1007\/s11065-020-09473-1","volume":"31","author":"G Maggi","year":"2021","unstructured":"Maggi, G., Trojano, L., Barone, P. & Santangelo, G. Sleep disorders and cognitive dysfunctions in Parkinson\u2019s disease: A meta-analytic study. Neuropsychol. Rev. 31, 643\u2013682. https:\/\/doi.org\/10.1007\/s11065-020-09473-1 (2021).","journal-title":"Neuropsychol. Rev."},{"issue":"7","key":"37644_CR32","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1093\/arclin\/13.7.575","volume":"13","author":"DA Cahn","year":"1998","unstructured":"Cahn, D. A. et al. differential contributions of cognitive and motor component processes to physical and instrumental activities of daily living in Parkinson\u2019s disease. Arch. Clin. Neuropsychol. 13(7), 575\u2013583. https:\/\/doi.org\/10.1093\/arclin\/13.7.575 (1998).","journal-title":"Arch. Clin. Neuropsychol."},{"issue":"2","key":"37644_CR33","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1037\/neu0000045","volume":"28","author":"E Pirogovsky","year":"2014","unstructured":"Pirogovsky, E. et al. Instrumental activities of daily living are impaired in Parkinson\u2019s disease patients with mild cognitive impairment. Neuropsychology 28(2), 229\u2013237. https:\/\/doi.org\/10.1037\/neu0000045 (2014).","journal-title":"Neuropsychology"},{"key":"37644_CR34","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1016\/j.jns.2018.02.032","volume":"387","author":"T Yousaf","year":"2018","unstructured":"Yousaf, T., Pagano, G., Niccolini, F. & Politis, M. Excessive daytime sleepiness may be associated with caudate denervation in Parkinson disease. J. Neurol. Sci. 387, 220\u2013227. https:\/\/doi.org\/10.1016\/j.jns.2018.02.032 (2018).","journal-title":"J. Neurol. Sci."},{"issue":"1","key":"37644_CR35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/npjparkd.2016.1","volume":"2","author":"S Perez-Lloret","year":"2016","unstructured":"Perez-Lloret, S. & Barrantes, F. J. Deficits in cholinergic neurotransmission and their clinical correlates in Parkinson\u2019s disease. Npj Parkinson\u2019s Dis. 2(1), 1\u201312. https:\/\/doi.org\/10.1038\/npjparkd.2016.1 (2016).","journal-title":"Npj Parkinson\u2019s Dis."},{"issue":"24","key":"37644_CR36","doi-asserted-by":"publisher","first-page":"2509","DOI":"10.1056\/NEJMoa041470","volume":"351","author":"M Emre","year":"2004","unstructured":"Emre, M. et al. Rivastigmine for dementia associated with Parkinson\u2019s disease. N. Engl. J. Med. 351(24), 2509\u20132518. https:\/\/doi.org\/10.1056\/NEJMoa041470 (2004).","journal-title":"N. Engl. J. Med."},{"issue":"15","key":"37644_CR37","doi-asserted-by":"publisher","first-page":"2175","DOI":"10.1002\/mds.22589","volume":"24","author":"D Aarsland","year":"2009","unstructured":"Aarsland, D., Marsh, L. & Schrag, A. Neuropsychiatric symptoms in Parkinson\u2019s disease. Mov. Disord. 24(15), 2175\u20132186. https:\/\/doi.org\/10.1002\/mds.22589 (2009).","journal-title":"Mov. Disord."},{"issue":"1","key":"37644_CR38","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1037\/\/0021-843x.105.1.97","volume":"105","author":"L B\u00e4ckman","year":"1996","unstructured":"B\u00e4ckman, L., Hill, R. D. & Forsell, Y. The influence of depressive symptomatology on episodic memory functioning among clinically nondepressed older adults. J. Abnorm. Psychol. 105(1), 97\u2013105. https:\/\/doi.org\/10.1037\/\/0021-843x.105.1.97 (1996).","journal-title":"J. Abnorm. Psychol."},{"key":"37644_CR39","doi-asserted-by":"publisher","first-page":"656","DOI":"10.2174\/156720510793611592","volume":"7","author":"K Iqbal","year":"2010","unstructured":"Iqbal, K., Liu, F., Gong, C.-X. & Grundke-Iqbal, I. Tau in Alzheimer disease and related Tauopathies. Curr. Alzheimer Res. 7, 656\u2013664. https:\/\/doi.org\/10.2174\/156720510793611592 (2010).","journal-title":"Curr. Alzheimer Res."},{"key":"37644_CR40","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1038\/nrneurol.2012.263","volume":"9","author":"CC Liu","year":"2013","unstructured":"Liu, C. C., Kanekiyo, T., Xu, H. & Bu, G. Apolipoprotein E and Alzheimer disease: Risk, mechanisms, and therapy. Nat. Rev. Neurol. 9, 106\u2013118. https:\/\/doi.org\/10.1038\/nrneurol.2012.263 (2013).","journal-title":"Nat. Rev. Neurol."},{"key":"37644_CR41","doi-asserted-by":"publisher","DOI":"10.1038\/s41380-021-01249-0","author":"H Hampel","year":"2021","unstructured":"Hampel, H. et al. The Amyloid-\u03b2 pathway in Alzheimer\u2019s disease. Mol. Psychiatry https:\/\/doi.org\/10.1038\/s41380-021-01249-0 (2021).","journal-title":"Mol. Psychiatry"},{"key":"37644_CR42","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1111\/bpa.12182","volume":"25","author":"DR Howlett","year":"2014","unstructured":"Howlett, D. R. et al. Regional multiple pathology scores are associated with cognitive decline in Lewy body dementias. Brain Pathol. 25, 401\u2013408. https:\/\/doi.org\/10.1111\/bpa.12182 (2014).","journal-title":"Brain Pathol."},{"key":"37644_CR43","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1007\/s007020200027","volume":"109","author":"KA Jellinger","year":"2002","unstructured":"Jellinger, K. A., Seppi, K., Wenning, G. K. & Poewe, W. Impact of coexistent Alzheimer pathology on the natural history of Parkinson\u2019s disease. J. Neural Transm. 109, 329\u2013339. https:\/\/doi.org\/10.1007\/s007020200027 (2002).","journal-title":"J. Neural Transm."},{"key":"37644_CR44","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1007\/s00401-008-0347-5","volume":"115","author":"KA Jellinger","year":"2008","unstructured":"Jellinger, K. A. & Attems, J. Prevalence and impact of vascular and Alzheimer pathologies in Lewy body disease. Acta Neuropathol. 115, 427\u2013436. https:\/\/doi.org\/10.1007\/s00401-008-0347-5 (2008).","journal-title":"Acta Neuropathol."},{"key":"37644_CR45","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1080\/13854046.2015.1087596","volume":"29","author":"SA Cooley","year":"2015","unstructured":"Cooley, S. A. et al. Longitudinal change in performance on the Montreal Cognitive Assessment in older adults. Clin. Neuropsychol. 29, 824\u2013835. https:\/\/doi.org\/10.1080\/13854046.2015.1087596 (2015).","journal-title":"Clin. Neuropsychol."},{"key":"37644_CR46","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1016\/S1474-4422(15)00093-9","volume":"14","author":"S Teipel","year":"2015","unstructured":"Teipel, S. et al. Multimodal imaging in Alzheimer\u2019s disease: Validity and usefulness for early detection. The Lancet Neurology 14, 1037\u20131053. https:\/\/doi.org\/10.1016\/S1474-4422(15)00093-9 (2015).","journal-title":"The Lancet Neurology"},{"key":"37644_CR47","doi-asserted-by":"publisher","first-page":"1952","DOI":"10.1038\/s41598-018-37769-z","volume":"9","author":"G Lee","year":"2019","unstructured":"Lee, G., Nho, K., Kang, B., Sohn, K. A. & Kim, D. Predicting Alzheimer\u2019s disease progression using multi-modal deep learning approach. Sci. Rep. 9, 1952. https:\/\/doi.org\/10.1038\/s41598-018-37769-z (2019).","journal-title":"Sci. Rep."},{"key":"37644_CR48","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1016\/j.neuroimage.2019.01.031","volume":"189","author":"S Spasov","year":"2019","unstructured":"Spasov, S., Passamonti, L., Duggento, A., Li\u00f2, P. & Toschi, N. A parameter-efficient deep learning approach to predict conversion from mild cognitive impairment to Alzheimer\u2019s disease. Neuroimage 189, 276\u2013287. https:\/\/doi.org\/10.1016\/j.neuroimage.2019.01.031 (2019).","journal-title":"Neuroimage"},{"key":"37644_CR49","doi-asserted-by":"publisher","first-page":"1460","DOI":"10.1002\/acn3.644","volume":"5","author":"K Marek","year":"2018","unstructured":"Marek, K. et al. The Parkinson\u2019s progression markers initiative (PPMI)\u2014Establishing a PD biomarker cohort. Ann. Clin. Transl. Neurol. 5, 1460\u20131477. https:\/\/doi.org\/10.1002\/acn3.644 (2018).","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"37644_CR50","doi-asserted-by":"publisher","DOI":"10.1111\/j.1532-5415.2005.53221.x","author":"ZS Nasreddine","year":"2005","unstructured":"Nasreddine, Z. S. et al. The montreal cognitive assessment, MoCA: A brief screening tool for mild cognitive impairment. J. Am. Geriatr. Soc. https:\/\/doi.org\/10.1111\/j.1532-5415.2005.53221.x (2005).","journal-title":"J. Am. Geriatr. Soc."},{"key":"37644_CR51","doi-asserted-by":"publisher","first-page":"171","DOI":"10.3389\/fnins.2012.00171","volume":"6","author":"A Klein","year":"2012","unstructured":"Klein, A. & Tourville, J. 101 Labeled brain images and a consistent human cortical labeling protocol. Front. Neurosci. 6, 171. https:\/\/doi.org\/10.3389\/fnins.2012.00171 (2012).","journal-title":"Front. Neurosci."},{"key":"37644_CR52","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1006\/nimg.1998.0395","volume":"9","author":"AM Dale","year":"1999","unstructured":"Dale, A. M., Fischl, B. & Sereno, M. I. Cortical surface-based analysis. I. Segmentation and surface reconstruction. Neuroimage 9, 179\u2013194. https:\/\/doi.org\/10.1006\/nimg.1998.0395 (1999).","journal-title":"Neuroimage"},{"key":"37644_CR53","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1016\/j.neuroimage.2012.01.021","volume":"62","author":"B Fischl","year":"2012","unstructured":"Fischl, B. FreeSurfer. Neuroimage 62, 774\u2013781. https:\/\/doi.org\/10.1016\/j.neuroimage.2012.01.021 (2012).","journal-title":"Neuroimage"},{"key":"37644_CR54","doi-asserted-by":"publisher","first-page":"11050","DOI":"10.1073\/pnas.200033797","volume":"97","author":"B Fischl","year":"2000","unstructured":"Fischl, B. & Dale, A. M. Measuring the thickness of the human cerebral cortex from magnetic resonance images. Proc. Natl. Acad. Sci. U.S.A. 97, 11050\u201311055. https:\/\/doi.org\/10.1073\/pnas.200033797 (2000).","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"37644_CR55","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1006\/nimg.1998.0396","volume":"9","author":"B Fischl","year":"1999","unstructured":"Fischl, B., Sereno, M. I. & Dale, A. M. Cortical surface-based analysis: II: Inflation, flattening, and a surface-based coordinate system. Neuroimage 9, 195\u2013207. https:\/\/doi.org\/10.1006\/nimg.1998.0396 (1999).","journal-title":"Neuroimage"},{"key":"37644_CR56","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/S0896-6273(02)00569-X","volume":"33","author":"B Fischl","year":"2002","unstructured":"Fischl, B. et al. Whole brain segmentation: Automated labeling of neuroanatomical structures in the human brain. Neuron 33, 341\u2013355. https:\/\/doi.org\/10.1016\/S0896-6273(02)00569-X (2002).","journal-title":"Neuron"},{"key":"37644_CR57","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.neuroimage.2015.04.042","volume":"115","author":"JE Iglesias","year":"2015","unstructured":"Iglesias, J. E. et al. A computational atlas of the hippocampal formation using ex vivo, ultra-high resolution MRI: Application to adaptive segmentation of in vivo MRI. Neuroimage 115, 117\u2013137. https:\/\/doi.org\/10.1016\/j.neuroimage.2015.04.042 (2015).","journal-title":"Neuroimage"},{"key":"37644_CR58","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1016\/j.neuroimage.2018.08.012","volume":"183","author":"JE Iglesias","year":"2018","unstructured":"Iglesias, J. E. et al. A probabilistic atlas of the human thalamic nuclei combining ex vivo MRI and histology. Neuroimage 183, 314\u2013326. https:\/\/doi.org\/10.1016\/j.neuroimage.2018.08.012 (2018).","journal-title":"Neuroimage"},{"key":"37644_CR59","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1016\/j.neuroimage.2017.04.046","volume":"155","author":"ZM Saygin","year":"2017","unstructured":"Saygin, Z. M. et al. High-resolution magnetic resonance imaging reveals nuclei of the human amygdala: Manual segmentation to automatic atlas. Neuroimage 155, 370\u2013382. https:\/\/doi.org\/10.1016\/j.neuroimage.2017.04.046 (2017).","journal-title":"Neuroimage"},{"key":"37644_CR60","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1038\/nrneurol.2017.27","volume":"13","author":"D Aarsland","year":"2017","unstructured":"Aarsland, D. et al. Cognitive decline in Parkinson disease. Nat. Rev. Neurol. 13, 217\u2013231. https:\/\/doi.org\/10.1038\/nrneurol.2017.27 (2017).","journal-title":"Nat. Rev. Neurol."},{"key":"37644_CR61","unstructured":"Robnik-Sikonja, M., & Kononenko, I. An adaptation of relief for attribute estimation in regression. In ICML\u201997 proceedings. (1997)."},{"key":"37644_CR62","unstructured":"Kira, K. & Rendell, L. A. The feature selection problem: traditional methods and a new algorithm. In AAAI-92 proceedings (1992)."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-37644-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-37644-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-37644-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,19]],"date-time":"2023-11-19T19:13:31Z","timestamp":1700421211000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-37644-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,14]]},"references-count":62,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["37644"],"URL":"https:\/\/doi.org\/10.1038\/s41598-023-37644-6","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,14]]},"assertion":[{"value":"3 November 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 June 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 August 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"13193"}}